NICE

Health and care professionals, stay updated with NICE's latest guidelines via our WhatsApp updates channel. 📱On mobile? Join here: whatsapp.com/channel/0029Va… 🖥️On desktop? Scan the QR code in the video. 🔔Once subscribed hit the bell to stay notified.

View NICE's priority topics for 2026-27 here: nice.org.uk/what-nice-does…

Our forward view sets out the areas we will prioritise each year. This year we’ve added a new section highlights the strategic areas we’ll be focusing on in guidance development, such as: ✅the 10 Year Health Plan ✅the modern service frameworks ✅biosimilars and generics

Just over 1,100 people with an aggressive form of lung cancer could be set to benefit after we recommended a new medicine in final draft guidance published today. Find out more about serplulimab: nice.org.uk/guidance/indev…

When a medicine's patent expires, lower-cost versions called biosimilars can be developed. A new taskforce is aligning regulation and NHS commissioning to speed up patient access. John Spoors and Danielle Lees, explain more: nice.org.uk/news/blogs/dri…

Our positive guidance recommendation has also been welcomed by @NHSEngland’s national clinical director for respiratory disease.

The chief executive of @asthmalunguk said today’s announcement could help thousands access a life-changing treatment.

Thousands of people with COPD could be set to benefit from a new targeted treatment recommended in final draft guidance today. Find out more about mepolizumab: nice.org.uk/guidance/indev…

⏰Webinar starting soon. NICE is consulting on a new approach to managing funding variation requests, join John Spoors and the funding variation taskforce to hear more about the proposals. Watch here: video.silverstream.tv/event/tfuPyUdE

We've updated our guidance on what should happen after someone is treated for a severe allergic reaction (anaphylaxis) in A&E. Some patients can now go home sooner if it's safe to do so, with an adrenaline pen and clear advice. Read more: nice.org.uk/guidance/ng258… @ResusCouncilUK

Thousands of people with advanced lung cancer now have a new treatment option on the NHS in England. We've recommended cemiplimab with chemotherapy for adults with untreated non-small-cell lung cancer. Find out more: nice.org.uk/guidance/indev…

“It has restored my life.” Joanne had suffered from migraines for a decade. Since being prescribed a new tablet recommended by NICE, she hasn't had a single attack. She's one of more than 20,000 people already benefitting. Explore our data story: nice.org.uk/news/articles/…

We’ve recommended tisotumab vedotin for treating cervical cancer that has returned or spread. It belongs to class of medicines called antibody-drug conjugates, which are designed to target and deliver cancer-killing medicine directly to tumour cells: nice.org.uk/guidance/indev…

Hundreds of people with non-small-cell lung cancer that cannot be removed by surgery could now access a new treatment option. We've recommended osimertinib in final guidance published today: nice.org.uk/guidance/ta115…

Fewer than 5% of rare diseases have an approved treatment. The average diagnosis takes over five years. We're proposing a new way forward, and we want to hear from patients, families and carers like you. Open to all, respond before 30th July 2026 – brnw.ch/21x2GHn

Great to see Dr Ranj raising awareness of the shift away from blue inhalers on @BBCMorningLive For every 10,000 people who switch to a combination inhaler, we estimate ▪️1,133 fewer GP visits ▪️144 fewer A&E visits ▪️80 fewer hospital admissions a year 🔗nice.org.uk/news/articles/…

“The technology is here. NICE is ensuring the NHS can use it, for everyone, in every part of the country.” @NICEComms Chief Executive Professor Jonathan Benger on AI, diagnostics, and NHS innovation. 👉 mag.nationalhealthexecutive.com/issue-108-q2/p… #HealthTech #AI #NHS #DigitalHealth

New draft guidance recommends NHS funding for liver perfusion machines, potentially increasing the number of successful transplants for the around 600 people waiting in England. Consultation open until 10 June: nice.org.uk/news/articles/…

CVDPREVENT's latest Data Pack supports ICBs with treating hypertension and lipid management. Get clear insights on NICE guidance implementation and spot opportunities to improve patient outcomes.

"No one can understand the process as well as a patient." Debra survived a heart attack at 38 and joined a NICE committee as a lay member to help shape our digital cardiac rehabilitation guidance. Patient perspective is at the heart of everything we do: indepth.nice.org.uk/from-patient-t…